Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Idhifa (Enasidenib) Medicine in India

Buy Idhifa (Enasidenib) Medicine in India

Idhifa (Enasidenib)

Medicine name : Idhifa

Generic name : Enasidenib

Manufactured By : Celgene

Indications : Relapsed or Refractory AML

Medicine Description : Idhifa is an IDH2 inhibitor for relapsed or refractory acute myeloid leukemia (AML) with IDH2 mutations. It blocks abnormal IDH2 proteins, reducing cancer cell growth. Taken orally, it offers a targeted approach. Side effects include differentiation syndrome, nausea, jaundice, and low blood counts. Patients require regular monitoring for differentiation syndrome, which can be life-threatening if untreated.

Product Introduction

Idhifa (Enasidenib) is a targeted anticancer medicine used to treat adults with relapsed or refractory acute myeloid leukemia (AML) whose cancer cells have a specific IDH2 mutation. Enasidenib works by blocking the abnormal IDH2 enzyme and reducing the production of substances that interfere with normal blood-cell development, helping leukemia cells mature and reducing their growth.

Idhifa (Enasidenib) should be taken exactly as prescribed by your doctor. It is usually taken once daily and may be taken with or without food. Swallow the tablet whole with water and do not crush, chew, or break it. Continue treatment for as long as recommended by your doctor. Regular blood tests and medical check-ups may be required to monitor your blood counts, liver function, and treatment response.

Common side effects of Idhifa (Enasidenib) may include nausea, vomiting, diarrhea, decreased appetite, fatigue, jaundice, and changes in blood cell counts. It can also cause a serious condition called differentiation syndrome, which may cause fever, weight gain, swelling, shortness of breath, or low blood pressure. Inform your doctor immediately if you experience these symptoms or other severe or unusual effects. Before starting treatment, tell your doctor about all medical conditions and medicines, vitamins, herbal products, or supplements you are taking.

Uses Of Idhifa (Enasidenib)

Treatment of IDH2-Mutated Acute Myeloid Leukemia

Benefits Of Idhifa

Idhifa (Enasidenib) is used to treat adults with relapsed or refractory acute myeloid leukemia (AML) whose cancer cells have a specific IDH2 mutation. It blocks the abnormal IDH2 enzyme and helps leukemia cells mature instead of remaining immature and abnormal. This can reduce the number of leukemia cells and may help control the progression of AML.

Side Effects Of Idhifa (Enasidenib)

Some side effects of Idhifa (Enasidenib) may improve as your body adjusts to the medicine. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Idhifa (Enasidenib)

  • Nausea
  • Vomiting
  • Diarrhea
  • Decreased appetite
  • Fatigue
  • Jaundice
  • Shortness of breath
  • Swelling
  • Fever
  • Increased bilirubin levels
How To Use Idhifa

Idhifa (Enasidenib) should be taken exactly as prescribed by your doctor. It is usually taken once daily and may be taken with or without food. Swallow the tablet whole with water and do not crush, chew, or break it. Take it at the same time each day and do not change the dose or stop treatment without consulting your doctor.

How Idhifa (Enasidenib) Works

Idhifa (Enasidenib) is a targeted therapy that blocks the abnormal IDH2 enzyme produced by certain mutated leukemia cells. The IDH2 mutation can cause the production of an abnormal substance that prevents immature blood cells from developing normally. By inhibiting mutant IDH2, Enasidenib helps leukemia cells mature and reduces their ability to grow, helping control relapsed or refractory IDH2-mutated acute myeloid leukemia (AML).

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Idhifa (Enasidenib).

PregnancyCONSULT YOUR DOCTOR

Idhifa (Enasidenib) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception as advised by your doctor.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Idhifa (Enasidenib) and for the recommended period after the final dose. Consult your doctor for guidance.

DrivingCONSULT YOUR DOCTOR

Idhifa (Enasidenib) may cause fatigue, dizziness, or other symptoms that can affect your ability to drive. Avoid driving if these effects occur.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may monitor kidney function during therapy.

LiverCAUTION

Tell your doctor if you have liver problems. Enasidenib can affect liver function and bilirubin levels, so regular monitoring may be required.

Quick Tips
  • Take Idhifa (Enasidenib) exactly as prescribed by your doctor and do not change or stop treatment without medical advice.
  • Drink adequate fluids as advised by your healthcare professional and report persistent vomiting or diarrhea.
  • Attend regular blood tests to monitor blood counts, bilirubin levels, liver function, and your response to treatment.
  • Contact your doctor immediately if you develop fever, sudden weight gain, swelling, shortness of breath, or other symptoms of differentiation syndrome.
  • Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible drug interactions.
  • Read More About - Idhifa (Enasidenib) from Pharma Five.
Faq

General Question

Idhifa (Enasidenib) is a prescription medication used to treat acute myeloid leukemia (AML) in adults with an IDH2 mutation who have relapsed or are resistant to previous treatment.

Idhifa works as an IDH2 inhibitor, blocking the mutated IDH2 enzyme to help restore normal blood cell production and slow cancer growth.

Idhifa is prescribed for adults with relapsed or refractory AML that has an IDH2 gene mutation, as confirmed by a doctor through genetic testing.

Idhifa is taken orally in tablet form, usually once daily, with or without food.

Common side effects of Idhifa include nausea, vomiting, diarrhea, decreased appetite, jaundice, and increased bilirubin levels.

Yes, Idhifa may cause differentiation syndrome, severe liver toxicity, and high blood bilirubin levels. Contact your doctor if severe symptoms appear.

Idhifa is typically taken as long as it remains effective and well-tolerated, or until the doctor advises stopping.

It is best to avoid alcohol while taking Idhifa, as it may worsen liver-related side effects.

No, Idhifa may harm an unborn baby. Women should use effective contraception while taking this medication.

Yes, Idhifa may interact with certain antibiotics, antifungals, and seizure medications. Inform your doctor of all medicines you take.

If you miss a dose, take it as soon as you remember. However, if it’s close to your next dose, skip the missed one. Do not take two doses at once.

Yes, Idhifa can be taken with or without food, but taking it with food may help reduce nausea.

Regular blood tests are necessary to monitor liver function and bilirubin levels. Avoid grapefruit and stay hydrated.

Store Idhifa at room temperature, away from moisture and heat, and keep it out of reach of children.

Idhifa is available by prescription at specialty pharmacies. Consult your doctor for the best source. Pharma Five assists in its procurement.